The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 19, 2021

Filed:

Sep. 24, 2015
Applicant:

Chugai Seiyaku Kabushiki Kaisha, Tokyo, JP;

Inventors:

Keiji Nogami, Nara, JP;

Midori Shima, Nara, JP;

Tetsuhiro Soeda, Shizuoka, JP;

Takehisa Kitazawa, Shizuoka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/86 (2006.01); C07K 16/36 (2006.01);
U.S. Cl.
CPC ...
G01N 33/86 (2013.01); C07K 16/36 (2013.01); C07K 2317/31 (2013.01); G01N 2333/755 (2013.01); G01N 2333/9645 (2013.01); G01N 2333/96444 (2013.01); G01N 2800/224 (2013.01); G01N 2800/52 (2013.01); G01N 2800/56 (2013.01);
Abstract

The inventors produced substances that neutralize the activity of a bispecific antibody having an activity of functionally substituting for FVIII, and undertook the construction of methods for measuring the reactivity of FVIII that can ensure accuracy even in the presence of this bispecific antibody. As a result, the inventors discovered that in APTT-based one-stage clotting assay, FVIII activity in the plasma of a hemophilia A patient can be evaluated accurately, and also that in APTT-based Bethesda assay, FVIII inhibitor titer in the plasma of a hemophilia A patient carrying a FVIII inhibitor can be evaluated accurately.


Find Patent Forward Citations

Loading…